Skip to main content

Table 1 Patients’ characteristics

From: Gallbladder function predicts subsequent biliary complications in patients with common bile duct stones after endoscopic treatment?

Parameter Number (%)
Gender (male) 76 (64.4%)
Age (mean±SD) 63.6±17.5 years
Smoking 31 (26.3%)
Alcohol drinking 18 (15.3%)
Concomitant disease
 Chronic lung diseases 7 (5.9%)
 Cerebrovascular diseases 7 (5.9%)
 Cardiovascular diseases 53 (44.9%)
 Renal failure 7 (5.9%)
 Cancer diseases 12 (10.2%)
 Liver disease 12 (10.2%)
 Diabetes mellitus 25 (21.2%)
Juxtapapillary diverticulum 45 (38.1%)
Gallbladder stones 86 (72.9%)
Biliary pancreatitis 24 (20.3%)
CBD diameter (mean±SD) 1.2±0.4 cm
Number of CBD stones (no/single /multiple) 23/59/36 (20/50/30)
Largest CBD stones size (mean±SD)a 0.9±0.4 cm
Endoscopic procedures (EST/EPBD) 5/113 (4/96)
Mean balloon diameter for EPBD (mean±SD) 1.1±0.2 cm
Mechanical lithotripsy 12 (10.2%)
Sessions for bile duct clearance(> 1 session) 8 (6.8%)
Stone colora
 Cholesterol and black pigment stones 44 (46%)
 Brown pigment stones 51 (54%)
Mean ERCP procedure time (mean±SD) 49.2±22.2 min
Postprocedural complications 4 (3.4%)
Follow up time (median, range) months 33 (15 to 56)
Recurrent biliary complications 23 (19.5%)
Spontaneous passage of gallstones 15 (15/86 = 17.4%)
Death during follow up 6 (5.1%)
  1. CBD: common bile duct, EST: endoscopic sphincterotomy, EPBD: endoscopic papillary balloon dilation
  2. a23 patients with stone pass-out were not included